Hjem › Blodlidelser › Georgia › Atlanta
Kliniske studier for Blodlidelser i Atlanta, GA
10 studier for Blodlidelser søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekruttererFase 3
- WCG Sonar Clinical Research, Riverdale · 12 mi unna
Treatment of Hemophilia A Patients With FVIII Inhibitors
RekruttererObservasjonsstudie
- Arthur M. Blank Hospital, Atlanta
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Emory University, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
- Winship Cancer Institute - Emory University, Atlanta
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Emory University, Atlanta
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- Emory University Hospital, Atlanta
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RekruttererObservasjonsstudie
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
- Emory/Children's Health Care of Atlanta, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
RekruttererFase 2
- Northside Hospital, Atlanta
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
RekruttererFase 1
- Northside Hospital, Atlanta
Blodlidelser-studier i andre byer
- Boston, MA10 studier
- Houston, TX9 studier
- Los Angeles, CA9 studier
- The Bronx, NY8 studier
- Nashville, TN7 studier
- New York City, NY7 studier
- Mountain View, CA6 studier
- Seattle, WA5 studier
- Durham, NC5 studier
- Washington, DC5 studier
- Portland, OR5 studier
- Greenville, NC5 studier
Andre studier i Atlanta
- Kreft (alle typer)49 studier
- Ikke-småcellet lungekreft47 studier
- Multipelt myelom42 studier
- Brystkreft41 studier
- Prostatakreft33 studier
- Akut myelogen leukemi31 studier
- Eggstokkreft29 studier
- Kolorektal kreft29 studier
- Lungekreft29 studier
- Metastatisk kreft28 studier
- Major depresjon25 studier
- Hjertesvikt25 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.